Evaluating in vivo efficacy – toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells

#JITC Research: Evaluating in vivo efficacy – toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells https://t.co/apGGBLGGPj https://t.co/XfnWTAKImT

#JITC Research: Evaluating in vivo efficacy – toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells https://t.co/apGGBLGGPj https://t.co/nH1MSYqm5o

RT @forum_gd: In vivo efficacy – toxicity profile of TEG001 in humanized mice xenografts against primary human AML #gdTcells @JKuball http…

RT @forum_gd: In vivo efficacy – toxicity profile of TEG001 in humanized mice xenografts against primary human AML #gdTcells @JKuball http…